February: covid-bloodclot, News and features
4.7 (621) · $ 11.99 · In stock
The risk of blood clots after COVID-19 vaccinations is very low finds a new study of 46-million adults in England. The research, which involved University of Bristol academics, showed that people vaccinated with Oxford-AstraZeneca or Pfizer-BioNTech had a lower risk of all venous clots (such as deep vein thrombosis and pulmonary embolism) and all arterial clots (such as strokes and heart attacks), particularly in people over 70 years.
Higher risk of blood clots in COVID-19 outpatients, largely reduced after vaccination — Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
Risk of Venous Thromboembolism after COVID-19 Low in Non-Hospitalized Patients
Genetic risk factor for clotting after COVID-19 infection - Medicine, Nursing and Health Sciences
Expert Says There's An 'Incredible Association' Between Blood Clots And COVID-19
Blood thinners being used to mitigate risk of clots in COVID-19 patients - CBS News
Deadly COVID-19 blood clot leads to first-ever intervention
Increased risk of blood clots in covid patients with specific gene variant - SciLifeLab
Blood thinners and COVID: The findings guiding patient care
MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots
Blood Clot Risk from COVID-19 Higher than After Vaccines: Study
